Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvan... Read More

Singapore Clinical Trial: A Phase 1, Open Label, Multiple-Dose Study to Assess the Changes in Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease Following Treatment with LY3439539 in Participants with Symptomatic Alzheimer’s Disease

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open Label, Multiple-Dose Study to Assess the Changes in Cerebrospinal Fluid Biomarker... Read More

Singapore Clinical Trial: Evaluating the efficacy and safety of Platelet Rich Plasma for patients with Peyronie’s disease: A pilot study

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'Evaluating the efficacy and safety of Platelet Rich Plasma for patients with Peyronie’s disease: ... Read More

Singapore Clinical Trial: SURFactant Administration by SUPraglottic Airway (the SURFSUP Trial)

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'SURFactant Administration by SUPraglottic Airway (the SURFSUP Trial)'. The following are the othe... Read More

Singapore Clinical Trial: An open-label, multi-center, phase I/II study of GVV858 as a single agent and in combination with endocrine therapy in patients with advanced hormone receptor positive, HER2-negative breast cancer and other advanced solid tumors

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'An open-label, multi-center, phase I/II study of GVV858 as a single agent and in combination with... Read More

Singapore Clinical Trial: A Single-arm Phase 2 Multicenter Study of Evorpacept in Combination with Trastuzumab and Chemotherapy in Participants with Metastatic HER2-Positive Breast Cancer

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'A Single-arm Phase 2 Multicenter Study of Evorpacept in Combination with Trastuzumab and Chemothe... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label Study of Belzutifan + Zanzalintinib Versus Cabozantinib in Participants with Advanced RCC who Experienced Disease Recurrence During or After Prior Adjuvant Anti-PD-1/L1 Therapy (LITESPARK-033)

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label Study of Belzutifan + Zanzalintinib Versus Cabozantinib in Part... Read More

Baloch student Imran Ali's death requires independent probe, claims Baloch Yakjehti Committee

Balochistan, Sept. 18 -- The Baloch Yakjehti Committee (BYC) has raised concerns over the alleged enforced disappearance and subsequent death of 20-year-old Baloch student Imran Ali, calling for a pro... Read More

Udhampur Police arrests absconder wanted in NDPS case

Udhampur, Sept. 18 -- Police team of PS Rehambal arrested an absconder namely Abdul Rashid S/O Ghulam Nabi R/O Garnai, Tehsil & District Udhampur who was wanted in connection with FIR No. 38/2024 U/S ... Read More

Singapore Clinical Trial: A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety and efficacy of efimosfermin alfa injection in adult participants with compensated cirrhosis (stage F4 fibrosis) due to metabolic dysfunction-associated steatohepatitis (NEBULA-2)

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety... Read More

• ««
• «
• 3486
• 3487
• 3488
• 3489
• 3490
• 3491
• 3492
• 3493
• 3494
• 3495
• »
• »»